Metraipolis › archive › dc_5cdb8cbb2ea7

Differences in Glycoproteins and the Potential for Early Protection Using LAIV Based on Drift Variants of the A/H1N1pdm09 Influenza Virus — Europe PMC PMID:41012169

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41012169
DOI
10.3390/vaccines13090966
License (as archived)
solo-consultazione
Archived
2026-11-10T00:46:30.837Z
SHA-256 of the archived text
b1279263d103b03221cb95de5af4d39038a8ffcba3fcd94bd9a49f63d67025c5
Stable URL of this page
https://metraipolis.com/documento/dc_5cdb8cbb2ea7

How to cite

Differences in Glycoproteins and the Potential for Early Protection Using LAIV Based on Drift Variants of the A/H1N1pdm09 Influenza Virus — Europe PMC PMID:41012169 — Europe PMC (en), https://europepmc.org/article/MED/41012169 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5cdb8cbb2ea7 (Metraipolis archive dc_5cdb8cbb2ea7, sha256 b1279263d103b03221cb95de5af4d39038a8ffcba3fcd94bd9a49f63d67025c5)
BibTeX
@misc{dc5cdb8cbb2ea7,
  title = {Differences in Glycoproteins and the Potential for Early Protection Using LAIV Based on Drift Variants of the A/H1N1pdm09 Influenza Virus — Europe PMC PMID:41012169},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41012169},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5cdb8cbb2ea7; sha256 b1279263d103b03221cb95de5af4d39038a8ffcba3fcd94bd9a49f63d67025c5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41012169. Agents can read the archived copy with the MCP tool read_document.